METRONIDAZOLE PREVENTION OF SERUM LIVER-ENZYME ABNORMALITIES DURING TOTAL PARENTERAL-NUTRITION

被引：49

作者：

LAMBERT, JR

THOMAS, SM

机构：

[1] MONASH UNIV, DEPT MED, GASTROENTEROL UNIT, MELBOURNE, VIC 3004, AUSTRALIA

[2] PRINCE HENRYS HOSP, DEPT PHARM, MELBOURNE, VIC 3004, AUSTRALIA

来源：

关键词：

D O I：

10.1177/0148607185009004501

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

引用

页码：501 / 503

页数：3

共 16 条

[1] ALLARDYCE DB, 1982, SURG GYNECOL OBSTET, V154, P641
[2] BENJAMIN DR, 1981, AM J CLIN PATHOL, V76, P276
[3] CAPRON, 1983, LANCET, V1, P446
[4] DRENICK EJ, 1982, GASTROENTEROLOGY, V82, P535
[5] ELLEBY H, 1983, LANCET, V1, P1161
[6] FOUINFORTUNET H, 1982, GASTROENTEROLOGY, V82, P932
[7] DRUG-THERAPY - METRONIDAZOLE
GOLDMAN, P
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (21) : 1212 - 1218
[8] LABROOY SJ, 1983, GUT, V24, pA996
[9] LIVER-FUNCTION VALUES IN ADULTS RECEIVING TOTAL PARENTERAL-NUTRITION
LINDOR, KD
FLEMING, CR
ABRAMS, A
HIRSCHKORN, MA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (22): : 2398 - 2400
[10] MALLORY A, 1973, GASTROENTEROLOGY, V64, P26